Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance

Stem Cells

Volumn 27, Issue 10, 2009, Pages 2488-2497

  Altarche Xifró, Wassim ^a   Curato, Caterina ^a   Kaschina, Elena ^a   Grzesiak, Aleksandra ^a   Slavic, Svetlana ^a   Dong, Jun ^b   Kappert, Kai ^a   Steckelings, Muscha ^a   Imboden, Hans ^c   Unger, Thomas ^a   Li, Jun ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Rheumatism Research Centre   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiotensin AT2 receptor; Cardiac c kit+ cell; Myocardial infarction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; MYC PROTEIN; NOTCH2 RECEPTOR; PROTEIN KINASE B; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL ISOLATION; CELL POPULATION; CELL RENEWAL; CELL SELECTION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TRANSCRIPTION REGULATION; UPREGULATION;

ANGIOTENSINS; ANIMALS; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOPROTECTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS;

RATTUS;

EID: 70350241656     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.171     Document Type: Article

References (37)

1. de Gasparo M, Catt KJ, Inagami T et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-472.
2. Busche S, Gallinat S, Bohle RM et al. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am J Pathol 2000;157:605-611.
3. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-1935.
4. Adachi Y, Saito Y, Kishimoto I et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003;107:2406-2408. (Pubitemid 36605220)
5. Kaschina E, Grzesiak A, Li J et al. Angiotensin II type 2 receptor stimulation: A novel option of therapeutic interference with the reninangiotensin system in myocardial infarction? Circulation 2008;118: 2523-2532.
6. Tsutsumi Y, Matsubara H, Ohkubo N et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998;83:1035-1046. (Pubitemid 28520933)
7. Matsumoto T, Ozono R, Oshima T et al. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc Res 2000;46:73-81. (Pubitemid 30155947)
8. Nio Y, Matsubara H, Murasawa S et al. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.
9. Mukoyama M, Nakajima M, Horiuchi M et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-24542. (Pubitemid 23335456)
10. Li J, Culman J, Hortnagl H et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 2005;19: 617-619. (Pubitemid 40471263)
11. Lucius R, Gallinat S, Rosenstiel P et al. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 1998;188:661-670. (Pubitemid 28387929)
12. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114: 763-776. (Pubitemid 37186770)
13. Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017. (Pubitemid 35440281)
14. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973. (Pubitemid 37376928)
15. Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127-137. (Pubitemid 40095762)
16. Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877. (Pubitemid 44033311)
17. Wan Y, Wallinder C, Plouffe B et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004;47:5995-6008. (Pubitemid 39507341)
18. Ribble D, Goldstein NB, Norris DA et al. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005;5:12. (Pubitemid 41460779)
19. Kajstura J, Cigola E, Malhotra A et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29: 859-870. (Pubitemid 27196513)
20. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000;182:311-322.
21. Grëpin C, Robitaille L, Antakly T et al. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol 1995;15:4095-4102.
22. Rutenberg JB, Fischer A, Jia H et al. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 2006;133:4381-4390. (Pubitemid 44830679)
23. Stoll M, Steckelings UM, Paul M et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657.
24. Nakajima M, Hutchinson HG, Fujinaga M et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995;92:10663-10667.
25. Tsuzuki S, Matoba T, Eguchi S et al. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension 1996;28:916-918. (Pubitemid 26365541)
26. Ohkubo N, Matsubara H, Nozawa Y et al. Angiotensin type 2 receptors are Reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997;96:3954-3962. (Pubitemid 27506054)
27. Côté F, Do TH, Laflamme L et al. Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 1999;274: 31686-31692. (Pubitemid 129501631)
28. Kilian P, Campbell S, Bilodeau L et al. Angiotensin II Type 2 receptor stimulation increases the rate of NG108-15 cell migration via actin depolymerization. Endocrinology 2008;149:2923-2933. (Pubitemid 351724517)
29. Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003;100:10440-10445. (Pubitemid 37071897)
30. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004;364:141-148. (Pubitemid 38891685)
31. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the Randomized, Controlled Boost (Bone Marrow Transfer To Enhance ST-elevation Infarct Regeneration) Trial. Circulation 2006; 113:1287-1294.
32. Saraste A, Pulkki K, Kallajoki M et al. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323. (Pubitemid 27056193)
33. Iwanami J, Mogi M, Li J-M et al. Deletion of Angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008; 39:2554-2559.
34. Matsui T, Li L, del Monte F et al. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999;100:2373-2379.
35. Suleman N, Somers S, Smith R et al. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 2008;79:127-133. (Pubitemid 351881934)
36. Burchfield JS, Iwasaki M, Koyanagi M et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008;103:203-211.
37. Ebelt H, Jungblut M, Zhang Y et al. Cellular cardiomyoplasty: Improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007;25:236-244. (Pubitemid 46052995)